1
|
Sánchez-Díaz M, Flórez Á, Ara-Martín M, Arias-Santiago S, Botella-Estrada R, Cañueto J, Carretero-Hernández G, Coto-Segura P, de Eusebio-Murillo E, García-Latasa de Araníbar FJ, García-Patos Briones V, Gardeazabal García J, Gómez-Fernández C, Hernández-Ostiz S, Izu Belloso R, López-Ávila A, Manchado López P, Martín-Santiago A, Martinez de Espronceda Ezquerro I, Mateu-Puchades A, Mercader-García P, Notario Rosa J, Palacio Aller L, Pérez-Hortet C, Quintana-Castanedo L, Rivera R, Rocamora Duran V, Rodríguez-Nevado IM, Ruiz-Villaverde R, Suárez J, Trasobares-Marugán L, Vizán-de Uña C, Yanguas I, Zulaica-Garate A, García-Doval I, Descalzo MÁ, Grau-Pérez M, Carrascosa-Carrillo JM. [Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study. Actas Dermosifiliogr 2024; 115:T237-T245. [PMID: 38242435 DOI: 10.1016/j.ad.2024.01.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Accepted: 10/09/2023] [Indexed: 01/21/2024] Open
Abstract
BACKGROUND Although the Spanish Ministry of Health prepares national therapeutic positioning reports (TPRs) and drug reimbursement policies, each of the country's 17 autonomous communities (ACs) is responsible for health care services and prescription requirements in its territory. The aim of the EQUIDAD study was to describe and explore potential differences in prescription requirements for new dermatology drugs across the autonomous communities. MATERIAL AND METHODS Cross-sectional study conducted in April and May, 2023. Two dermatologists with management responsibilities from each autonomous community reported on territorial and more local prescription requirements for drugs covered by national TPRs issued between 2016 and 2022. RESULTS Thirty-three researchers from 17 autonomous communities participated. The data submitted revealed between-community inequities in access to new drugs. Overall, 64.7% of the regions imposed additional prescription requirements to those mentioned in the TPRs for psoriasis. This percentage was lower for atopic dermatitis (35.3%) and melanoma (11.8%). The most common requirement for accessing a new drug was a previous prescription for another drug. Differences and additional requirements were also detected at the local level (i.e., differences between hospitals within the same autonomous community). CONCLUSIONS Spain's autonomous communities have multiple regional and local prescription requirements that are not aligned with national TPR recommendations. These differences result in inequitable access to new drugs for both patients and practitioners across Spain.
Collapse
Affiliation(s)
- M Sánchez-Díaz
- Unidad de Investigación, Academia Española de Dermatología y Venereología, Madrid, Spain; Servicio de Dermatología, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria IBS, Granada, Spain
| | - Á Flórez
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Grupo de Investigación DIPO, IIS Galicia Sur-SERGAS-UVIGO, Pontevedra, Spain
| | - M Ara-Martín
- Servicio de Dermatología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
| | - S Arias-Santiago
- Servicio de Dermatología, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria IBS, Granada, Spain
| | - R Botella-Estrada
- Servicio de Dermatología, Hospital Universitario La Fe, Valencia, Spain
| | - J Cañueto
- Servicio de Dermatología, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain
| | - G Carretero-Hernández
- Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
| | - P Coto-Segura
- Servicio de Dermatología, Hospital Vital Alvarez-Buylla, Mieres, Asturias, Spain
| | - E de Eusebio-Murillo
- Servicio de Dermatología, Hospital Universitario de Guadalajara, Guadalajara, Spain
| | | | - V García-Patos Briones
- Servicio de Dermatología, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - J Gardeazabal García
- Servicio de Dermatología, Hospital Universitario Cruces, Barakaldo, Vizcaya, Spain
| | - C Gómez-Fernández
- Servicio de Dermatología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
| | - S Hernández-Ostiz
- Servicio de Dermatología, Hospital de Calahorra, Calahorra, La Rioja, Spain
| | - R Izu Belloso
- Servicio de Dermatología, Hospital Universitario Basurto, Bilbao, Vizcaya, Spain
| | - A López-Ávila
- Servicio de Dermatología, Hospital General Universitario Santa María del Rosell, Cartagena, Spain
| | - P Manchado López
- Servicio de Dermatología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
| | - A Martín-Santiago
- Servicio de Dermatología, Hospital Universitari Son Espases, Palma de Mallorca, Baleares, Spain
| | | | - A Mateu-Puchades
- Servicio de Dermatología, Hospital Universitario Doctor Peset, Valencia, Spain
| | | | - J Notario Rosa
- Servicio de Dermatología, Hospital Universitario de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain
| | - L Palacio Aller
- Servicio de Dermatología, Hospital de Cabueñes, Gijón, Asturias, Spain
| | - C Pérez-Hortet
- Servicio de Dermatología, Hospital Universitario de Toledo, Toledo, Spain
| | - L Quintana-Castanedo
- Servicio de Dermatología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
| | - R Rivera
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - V Rocamora Duran
- Servicio de Dermatología, Hospital de Manacor, Manacor, Baleares, Spain
| | - I M Rodríguez-Nevado
- Servicio de Dermatología, Complejo Hospitalario Universitario de Badajoz, Badajoz, Spain
| | - R Ruiz-Villaverde
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, Spain
| | - J Suárez
- Servicio de Dermatología, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain
| | - L Trasobares-Marugán
- Servicio de Dermatología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
| | - C Vizán-de Uña
- Servicio de Dermatología, Hospital Universitario de Cáceres, Cáceres, Spain
| | - I Yanguas
- Servicio de Dermatología, Hospital Universitario de Navarra, Pamplona, Spain
| | - A Zulaica-Garate
- Servicio de Dermatología, Hospital do Meixoeiro, Vigo, Pontevedra, Spain
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, Spain
| | - M Á Descalzo
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, Spain
| | - M Grau-Pérez
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, Spain; Servicio de Dermatología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
| | - J M Carrascosa-Carrillo
- Servicio de Dermatología, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain
| |
Collapse
|
2
|
Sánchez-Díaz M, Flórez Á, Ara-Martín M, Arias-Santiago S, Botella-Estrada R, Cañueto J, Carretero-Hernández G, Coto-Segura P, de Eusebio-Murillo E, García-Latasa de Araníbar FJ, García-Patos Briones V, Gardeazabal García J, Gómez-Fernández C, Hernández-Ostiz S, Izu Belloso R, López-Ávila A, Manchado López P, Martín-Santiago A, Martinez de Espronceda Ezquerro I, Mateu-Puchades A, Mercader-García P, Notario Rosa J, Palacio Aller L, Pérez-Hortet C, Quintana-Castanedo L, Rivera R, Rocamora Duran V, Rodríguez-Nevado IM, Ruiz-Villaverde R, Suárez J, Trasobares-Marugán L, Vizán-de Uña C, Yanguas I, Zulaica-Garate A, García-Doval I, Descalzo MÁ, Grau-Pérez M, Carrascosa-Carrillo JM. Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study. Actas Dermosifiliogr 2024; 115:237-245. [PMID: 37890617 DOI: 10.1016/j.ad.2023.10.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Revised: 09/26/2023] [Accepted: 10/09/2023] [Indexed: 10/29/2023] Open
Abstract
BACKGROUND Although the Spanish Ministry of Health prepares national therapeutic positioning reports (TPRs) and drug reimbursement policies, each of the country's 17 autonomous communities (ACs) is responsible for health care services and prescription requirements in its territory. The aim of the EQUIDAD study was to describe and explore potential differences in prescription requirements for new dermatology drugs across the autonomous communities. MATERIAL AND METHODS Cross-sectional study conducted in April and May, 2023. Two dermatologists with management responsibilities from each autonomous community reported on territorial and more local prescription requirements for drugs covered by national TPRs issued between 2016 and 2022. RESULTS Thirty-three researchers from 17 autonomous communities participated. The data submitted revealed between-community inequities in access to new drugs. Overall, 64.7% of the regions imposed additional prescription requirements to those mentioned in the TPRs for psoriasis. This percentage was lower for atopic dermatitis (35.3%) and melanoma (11.8%). The most common requirement for accessing a new drug was a previous prescription for another drug. Differences and additional requirements were also detected at the local level (i.e., differences between hospitals within the same autonomous community). CONCLUSIONS Spain's autonomous communities have multiple regional and local prescription requirements that are not aligned with national TPR recommendations. These differences result in inequitable access to new drugs for both patients and practitioners across Spain.
Collapse
Affiliation(s)
- M Sánchez-Díaz
- Unidad de Investigación, Academia Española de Dermatología y Venereología, Madrid, España; Servicio de Dermatología, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria IBS, Granada, España
| | - Á Flórez
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Grupo de Investigación DIPO, IIS Galicia Sur-SERGAS-UVIGO, Pontevedra, España
| | - M Ara-Martín
- Servicio de Dermatología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España
| | - S Arias-Santiago
- Servicio de Dermatología, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria IBS, Granada, España
| | - R Botella-Estrada
- Servicio de Dermatología, Hospital Universitario La Fe, Valencia, España
| | - J Cañueto
- Servicio de Dermatología, Complejo Asistencial Universitario de Salamanca, Salamanca, España
| | - G Carretero-Hernández
- Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, España
| | - P Coto-Segura
- Servicio de Dermatología, Hospital Vital Alvarez-Buylla, Mieres, Asturias, España
| | - E de Eusebio-Murillo
- Servicio de Dermatología, Hospital Universitario de Guadalajara, Guadalajara, España
| | | | - V García-Patos Briones
- Servicio de Dermatología, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España
| | - J Gardeazabal García
- Servicio de Dermatología, Hospital Universitario Cruces, Barakaldo, Vizcaya, España
| | - C Gómez-Fernández
- Servicio de Dermatología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España
| | - S Hernández-Ostiz
- Servicio de Dermatología, Hospital de Calahorra, Calahorra, La Rioja, España
| | - R Izu Belloso
- Servicio de Dermatología, Hospital Universitario Basurto, Bilbao, Vizcaya, España
| | - A López-Ávila
- Servicio de Dermatología, Hospital General Universitario Santa María del Rosell, Cartagena, España
| | - P Manchado López
- Servicio de Dermatología, Hospital Clínico Universitario de Valladolid, Valladolid, España
| | - A Martín-Santiago
- Servicio de Dermatología, Hospital Universitari Son Espases, Palma de Mallorca, Baleares, España
| | | | - A Mateu-Puchades
- Servicio de Dermatología, Hospital Universitario Doctor Peset, Valencia, España
| | | | - J Notario Rosa
- Servicio de Dermatología, Hospital Universitario de Bellvitge, L' Hospitalet de Llobregat, Barcelona, España
| | - L Palacio Aller
- Servicio de Dermatología, Hospital de Cabueñes, Gijón, Asturias, España
| | - C Pérez-Hortet
- Servicio de Dermatología, Hospital Universitario de Toledo, Toledo, España
| | - L Quintana-Castanedo
- Servicio de Dermatología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España
| | - R Rivera
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España
| | - V Rocamora Duran
- Servicio de Dermatología, Hospital de Manacor, Manacor, Baleares, España
| | - I M Rodríguez-Nevado
- Servicio de Dermatología, Complejo Hospitalario Universitario de Badajoz, Badajoz, España
| | - R Ruiz-Villaverde
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, España
| | - J Suárez
- Servicio de Dermatología, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, España
| | - L Trasobares-Marugán
- Servicio de Dermatología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, España
| | - C Vizán-de Uña
- Servicio de Dermatología, Hospital Universitario de Cáceres, Cáceres, España
| | - I Yanguas
- Servicio de Dermatología, Hospital Universitario de Navarra, Pamplona, España
| | - A Zulaica-Garate
- Servicio de Dermatología, Hospital do Meixoeiro, Vigo, Pontevedra, España
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, España
| | - M Á Descalzo
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, España
| | - M Grau-Pérez
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, España; Servicio de Dermatología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.
| | - J M Carrascosa-Carrillo
- Servicio de Dermatología, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, España
| |
Collapse
|
3
|
Cuenca-Barrales C, Baselga-Torres E, del Boz-González J, Vicente A, Palencia-Pérez S, Campos-Domínguez M, Valdivieso-Ramos M, Martín-Santiago A, Montserrat-García M, Azón-Masoliver A, Feito-Rodríguez M, Domínguez-Cruz J, Roé-Crespo E, Salas-Márquez C, Giacaman A, Lorente-Lavirgen A, Quintana-Castanedo L, de Vega-Martínez M, García-Doval I, Bernabéu-Wittel J. Baseline Description of the Spanish Academy of Dermatology Infantile Haemangioma Nationwide Prospective Cohort. Comparison of Patients Treated with Propranolol in Routine Clinical Practice with Previous Pivotal Clinical Trial Data. Actas Dermo-Sifiliográficas (English Edition) 2021. [DOI: 10.1016/j.adengl.2021.08.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
4
|
Cuenca-Barrales C, Baselga-Torres E, Del Boz-González J, Vicente A, Palencia-Pérez SI, Campos-Domínguez M, Valdivieso-Ramos M, Martín-Santiago A, Montserrat-García MT, Azón-Masoliver A, Feito-Rodríguez M, Domínguez-Cruz JJ, Roé-Crespo E, Salas-Márquez C, Giacaman A, Lorente-Lavirgen AI, Quintana-Castanedo L, de Vega-Martínez M, García-Doval I, Bernabéu-Wittel J. Baseline description of the Spanish Academy of Dermatology infantile haemangioma nationwide prospective cohort. Comparison of patients treated with propranolol in routine clinical practice with previous pivotal clinical trial data. Actas Dermosifiliogr (Engl Ed) 2021; 112:S0001-7310(21)00198-8. [PMID: 34052200 DOI: 10.1016/j.ad.2021.05.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2021] [Revised: 05/12/2021] [Accepted: 05/17/2021] [Indexed: 01/14/2023] Open
Abstract
BACKGROUND There are several therapeutic options for infantile haemangiomas (IH). Propranolol is used according to a pivotal trial. We aimed to describe the characteristics of IH in clinical practice, including the therapies used, and to compare the characteristics of patients treated with propranolol with those of the trial to assess its external validity. METHODS Consecutive patients attending 12 Spanish hospitals from June 2016 to October 2019 were included (n=601). RESULTS The mean age was 3.9 (SD:1.9) months, with a 2:1 female-to-male ratio. Most IHs were localized (82%, 495), superficial (64%, 383) and located in the face (25%, 157) and trunk (31%, 188). Median size was 17 (IR: 10-30) x 12 (IR: 7-20) mm. Complications were found in 16 (3%) patients. Treatment was initiated for 52% (311). Most patients received timolol (76%, 237); propranolol was reserved for complications or high-risk IHs. Aesthetic impairment was the main reason for starting therapy (64%, 199). Several characteristics of the patients and IHs treated with propranolol are similar to those of the pivotal clinical trial, but 1/3 of IHs did not reach the minimum diameter to meet the inclusion criteria, and important prognostic information was not reported. CONCLUSIONS As most patients receive treatment for aesthetic impairment, there is a need to better understand the aesthetic results of therapies and to increase evidence on the use of timolol, which is currently the most common therapy. Propranolol is being used in a population generally similar to that of the trial; however, this statement cannot be definitely confirmed.
Collapse
Affiliation(s)
- C Cuenca-Barrales
- Unidad de investigación, Fundación Piel Sana Academia Española de Dermatología y Venereología, Madrid, España; Departamento de Dermatología, Hospital Universitario Virgen de las Nieves, Granada, España; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, España.
| | - E Baselga-Torres
- Departamento de Dermatología, Hospital Sant Joan de Déu, Barcelona, España; Clínica Dermik, Barcelona, España
| | - J Del Boz-González
- Departamento de Dermatología, Hospital Costa del Sol, Marbella, Málaga, España
| | - A Vicente
- Departamento de Dermatología, Hospital Sant Joan de Déu, Barcelona, España
| | | | | | | | - A Martín-Santiago
- Departamento de Dermatología, Hospital Son Espases, Palma de Mallorca, España
| | - M T Montserrat-García
- Departamento de Dermatología, Hospital Virgen del Rocío, Sevilla, España; Departamento de Dermatología, Hospital Viamed Santa Ángela de la Cruz, Sevilla, España
| | - A Azón-Masoliver
- Departamento de Dermatología, Hospital Sant Joan de Reus, Tarragona, España
| | | | - J J Domínguez-Cruz
- Departamento de Dermatología, Hospital Virgen del Rocío, Sevilla, España; Departamento de Dermatología, Hospital Viamed Santa Ángela de la Cruz, Sevilla, España
| | - E Roé-Crespo
- Departamento de Dermatología, Hospital Santa Creu i Sant Pau, Barcelona, España
| | - C Salas-Márquez
- Departamento de Dermatología, Hospital Costa del Sol, Marbella, Málaga, España
| | - A Giacaman
- Departamento de Dermatología, Hospital Son Espases, Palma de Mallorca, España
| | - A I Lorente-Lavirgen
- Departamento de Dermatología, Hospital Viamed Santa Ángela de la Cruz, Sevilla, España
| | | | - M de Vega-Martínez
- Unidad de investigación, Fundación Piel Sana Academia Española de Dermatología y Venereología, Madrid, España
| | - I García-Doval
- Unidad de investigación, Fundación Piel Sana Academia Española de Dermatología y Venereología, Madrid, España; Departamento de Dermatología, Complexo Hospitalario Universitario de Vigo, España
| | - J Bernabéu-Wittel
- Departamento de Dermatología, Hospital Virgen del Rocío, Sevilla, España; Departamento de Dermatología, Hospital Viamed Santa Ángela de la Cruz, Sevilla, España
| |
Collapse
|
5
|
Quintana-Castanedo L, Nieto-Rodríguez D, Feito-Rodríguez M. Rapid Appearance of Skin Lesions as the Only Sign of Superior Vena Cava Syndrome. Actas Dermosifiliogr 2021; 112 Suppl 1:21-22. [PMID: 33901483 DOI: 10.1016/j.ad.2020.04.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2019] [Revised: 03/27/2020] [Accepted: 04/14/2020] [Indexed: 10/21/2022] Open
Affiliation(s)
| | - D Nieto-Rodríguez
- Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España
| | - M Feito-Rodríguez
- Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España
| |
Collapse
|
6
|
Quintana-Castanedo L, Nieto-Rodríguez D, Rodríguez-Álvarez D, Feito-Rodríguez M, de Lucas-Laguna R. Toxic Epidermal Necrolysis in a Boy: Successful Treatment With Cyclosporine A. Actas Dermosifiliogr (Engl Ed) 2020; 112:468-470. [PMID: 33253652 DOI: 10.1016/j.ad.2019.10.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2019] [Revised: 10/18/2019] [Accepted: 10/28/2019] [Indexed: 11/26/2022] Open
Affiliation(s)
| | - D Nieto-Rodríguez
- Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España
| | - D Rodríguez-Álvarez
- Servicio de Cuidados Intensivos Pediátricos, Hospital Universitario La Paz, Madrid, España
| | - M Feito-Rodríguez
- Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España
| | - R de Lucas-Laguna
- Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España
| |
Collapse
|
7
|
Quintana-Castanedo L, Feito-Rodríguez M, Fernández-Alcalde C, Granados-Fernández M, Montero-Vega D, Mayor-Ibarguren A, de Lucas-Laguna R. Concurrent chilblains and retinal vasculitis in a child with COVID-19. J Eur Acad Dermatol Venereol 2020; 34:e764-e766. [PMID: 32618041 PMCID: PMC7361625 DOI: 10.1111/jdv.16801] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Affiliation(s)
| | - M Feito-Rodríguez
- Department of Dermatology, University Hospital La Paz, Madrid, Spain
| | | | | | - D Montero-Vega
- Department of Microbiology and Parasitology, La Paz University Hospital-Carlos III, Madrid, Spain
| | - A Mayor-Ibarguren
- Department of Dermatology, University Hospital La Paz, Madrid, Spain
| | - R de Lucas-Laguna
- Department of Dermatology, University Hospital La Paz, Madrid, Spain
| |
Collapse
|
8
|
Quintana-Castanedo L, Maseda-Pedrero R, Herranz-Pinto P. Erosive and crusty plaque located in the ear of a patient with a childhood burn history. Rev Clin Esp 2020. [DOI: 10.1016/j.rceng.2018.12.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|